Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Sichu Liu"'
Publikováno v:
Mathematics, Vol 12, Iss 12, p 1894 (2024)
Cooperative Technology Transfer (CTT) is a technology transfer model where universities and enterprises jointly participate throughout the entire process of technology transfer activities. Most discussions focus on its mechanisms and influencing fact
Externí odkaz:
https://doaj.org/article/2ee9dc526b4747d89400917175c6e216
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
Autor:
Cunte Chen, Zheng Chen, Ling Huang, Lingling Zhou, Lihua Zhu, Sichu Liu, Gengxin Luo, Wenyu Li, Chengwu Zeng, Yangqiu Li
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background T-cell lymphoma (TCL) is highly aggressive and has a poor prognosis; thus, it is worth exploring biomarkers that may predict clinical outcomes and investigate their potential role in developing targeted therapies. In this study, w
Externí odkaz:
https://doaj.org/article/8b74bc126b4e46bf97fec8b273101517
Autor:
Cunte Chen, Sichu Liu, Xinmiao Jiang, Ling Huang, Feili Chen, Xiaojun Wei, Hanguo Guo, Yang Shao, Yangqiu Li, Wenyu Li
Publikováno v:
Experimental Hematology & Oncology, Vol 10, Iss 1, Pp 1-11 (2021)
Abstract Background Tumor mutation burden (TMB) as estimated by cancer gene panels (CGPs) has been confirmed to be associated with prognosis and is effective in predicting clinical benefit from immune checkpoint blockade (ICB) in solid tumors. Howeve
Externí odkaz:
https://doaj.org/article/534ed6599fe44536ad68e5219fc195b9
Autor:
Feili Chen, Diwen Pang, Hanguo Guo, Qiuxiang Ou, Xue Wu, Xinmiao Jiang, Xiaojuan Wei, Sichu Liu, Ling Huang, Zhanli Liang, Dong Zhou, Wenyu Li
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8676-8684 (2020)
Abstract Ibrutinib‐based combination therapy with high‐dose methotrexate (HD‐MTX) has recently shown clinical activity against relapse/refractory (R/R) primary central nervous system lymphoma (PCNSL). Herein, we report our real‐world experien
Externí odkaz:
https://doaj.org/article/63ee5ec475d841519a86511adf7039bc
Autor:
Chengwu Zeng, Sichu Liu, Shuai Lu, Xibao Yu, Jing Lai, Yifan Wu, Shaohua Chen, Liang Wang, Zhi Yu, Gengxin Luo, Yangqiu Li
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-6 (2018)
Abstract Chronic myeloid leukemia (CML) is a clonal disease characterized by the presence of the constitutively active tyrosine kinase BCR-ABL oncoprotein. Although BCR-ABL is crucially important for pathogenesis and treatment response, it is thought
Externí odkaz:
https://doaj.org/article/c6d15df2bedb4331b87551536cc0be00
TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma
Autor:
Lihua Zhu, Cunte Chen, Sichu Liu, Lingling Zhou, Chengwu Zeng, Gengxin Luo, Wenyu Li, Ling Huang, Zheng Chen, Yangqiu Li
Publikováno v:
Cancer Cell International, Vol 21, Iss 1, Pp 1-10 (2021)
Cancer Cell International
Cancer Cell International
Background T-cell lymphoma (TCL) is highly aggressive and has a poor prognosis; thus, it is worth exploring biomarkers that may predict clinical outcomes and investigate their potential role in developing targeted therapies. In this study, we charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fcedbba3e4751b9aae6e5f6fae979bc
https://doaj.org/article/8b74bc126b4e46bf97fec8b273101517
https://doaj.org/article/8b74bc126b4e46bf97fec8b273101517
Autor:
Shu-Xia Wang, Fen Zhang, Feili Chen, Pek-Lan Khong, Hanguo Guo, Sichu Liu, Xiaojuan Wei, Yan-Ying Huang, Xinmiao Jiang, Hui Yuan, Peng-Jun Liao, Wenyu Li, Ling Huang
Publikováno v:
Acta Oncologica. 60:1122-1129
BACKGROUND The incidence of primary cardiac lymphoma (PCL) is increasing, but the optimal management approach remains unclear. We assessed the clinical characteristics of a single-centre cohort with the goal of determining the optimal management appr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bdfa2f2d58f33060edd400703ecbb77
https://doi.org/10.1080/0284186x.2021.1950923
https://doi.org/10.1080/0284186x.2021.1950923
Autor:
Yan Teng, Ling Huang, Guiping Chen, Xinmiao Jiang, Xiaojuan Wei, Hanguo Guo, Feili Chen, Sichu Liu, Shaojiang Yang, Qingqing Cai, Ning Wang, Lu Pan, Zhanli Liang, Zhigang Zhu, Ying Zhao, Wenyu Li
Publikováno v:
Journal of Cancer Research & Therapeutics; Mar2023, Vol. 19 Issue 1, Following p117-123, 8p
Autor:
Xue Wu, Diwen Pang, Zhanli Liang, Wenyu Li, Hanguo Guo, Feili Chen, Xiaojuan Wei, Sichu Liu, Ling Huang, Qiuxiang Ou, Dong Zhou, Xinmiao Jiang
Publikováno v:
Cancer Medicine, Vol 9, Iss 22, Pp 8676-8684 (2020)
Cancer Medicine
Cancer Medicine
Ibrutinib‐based combination therapy with high‐dose methotrexate (HD‐MTX) has recently shown clinical activity against relapse/refractory (R/R) primary central nervous system lymphoma (PCNSL). Herein, we report our real‐world experience of tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129c649ce82dbd3a326cdae4f335e512
https://doaj.org/article/63ee5ec475d841519a86511adf7039bc
https://doaj.org/article/63ee5ec475d841519a86511adf7039bc
Autor:
Xinmiao Jiang, Diwen Pang, Feili Chen, Xiaojuan Wei, Zhanli Liang, Sichu Liu, Ling Huang, Wenyu Li, Hanguo Guo, Xiaoxia Wang
Publikováno v:
Cancer Management and Research. 12:3003-3012
Purpose The purpose of this study is to perform a retrospective analysis of disease outcomes and mutational profiles in patients with adult T-cell lymphoblastic lymphoma (T-LBL). Patients and methods A total of 43 patients were treated over a 9-year
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7adb1caf1ddee5bba37d716d7e23b8c2
https://doi.org/10.2147/cmar.s242903
https://doi.org/10.2147/cmar.s242903